Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01821456
What this trial is testing

Cologne Cohort of Neutropenic Patients (CoCoNut)

Who this might be right for
Hematological MalignanciesCancerChemotherapy+2 more
University Hospital of Cologne 100,000
Not applicableActive Not RecruitingNCT04217356
What this trial is testing

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

Who this might be right for
MyelofibrosisHigh-Risk CancerBone Marrow Cancer
University Health Network, Toronto 90
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)UnknownNCT02794961
What this trial is testing

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

Who this might be right for
Recurrent or Refractory B Cell Malignancy
Kai Lin Xu; Jun Nian Zheng 10
Not applicableLooking for participantsNCT05768269
What this trial is testing

Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Who this might be right for
Hematological MalignancySolid Tumor Malignancy
Century Therapeutics, Inc. 375
Not applicableWithdrawnNCT00731705
What this trial is testing

In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplantation
Indiana University
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Testing effectiveness (Phase 2)Study completedNCT01423851
What this trial is testing

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

Who this might be right for
Primary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis
NS Pharma, Inc. 77
Early research (Phase 1)Study completedNCT02412722
What this trial is testing

A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies

Who this might be right for
Non-hematologic Malignancy
Millennium Pharmaceuticals, Inc. 61
Large-scale testing (Phase 3)Study completedNCT03125070
What this trial is testing

Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Fred Hutchinson Cancer Center 546
Testing effectiveness (Phase 2)Active Not RecruitingNCT04395222
What this trial is testing

Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

Who this might be right for
Hematologic MalignancyBone Marrow Transplant
Weill Medical College of Cornell University 21
Not applicableLooking for participantsNCT07472972
What this trial is testing

Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)

Who this might be right for
LymphomaLymphoid Hematological Malignancies
University of Zurich 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180
Not applicableStudy completedNCT05024331
What this trial is testing

A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor

Who this might be right for
Pediatric Solid Tumor
Samsung Medical Center 10
Early research (Phase 1)WithdrawnNCT02487459
What this trial is testing

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Bellicum Pharmaceuticals
Not applicableStudy completedNCT05132842
What this trial is testing

Cannabis Use Patterns Among Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 1,568
Testing effectiveness (Phase 2)Study completedNCT00410696
What this trial is testing

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Who this might be right for
Hematological NeoplasmsTumors
Armando Santoro, MD 80
Not applicableActive Not RecruitingNCT02515383
What this trial is testing

Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 41
Not applicableUnknownNCT05629260
What this trial is testing

The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Peking University People's Hospital 300
Testing effectiveness (Phase 2)UnknownNCT02685670
What this trial is testing

Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Next Page